Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
about
MicroRNA Processing and Human CancerKnocking down disease: a progress report on siRNA therapeuticsLoss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transitionMicroRNA-142-3p Negatively Regulates Canonical Wnt Signaling Pathway.Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer.Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse ModelInhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain developmentDirect Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse OriginDicer knockdown inhibits endothelial cell tumor growth via microRNA 21a-3p targeting of Nox-4.Delivering the promise of small ncRNA therapeutics.Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles.Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs.Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activation.β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.
P2860
Q26797308-D9A8AAE9-C763-4101-BA6A-CB9289052127Q28082939-2312E1D8-055A-45FC-878B-61E9244157B6Q35793817-5FBD379D-2085-424D-8852-79895360FDB6Q36062381-5509C8B4-618F-45AE-BD65-6BE99EC2DF97Q36532644-909D6162-FB23-4713-A12C-050176B87FA6Q36664787-62AE6CD5-281B-4203-9AB5-42D60844BB1CQ36764934-16DB0A62-D1B9-47BC-AAB3-078F76252F82Q36784555-8D439B86-0784-40BA-8147-C674D9D5D094Q36792563-669D8B2A-BCCA-48CD-99FA-E11548DC7D8CQ36951298-150836D6-D686-430A-8774-748A6E3C562BQ37115195-1CD4C5E0-2238-47C5-9EC6-B7F270DE5D51Q37231321-6AC75ACB-B968-4003-890F-2DE2B3CF311DQ37691678-BC5B6AC1-7FC0-48DA-A924-52E7116176A5Q38226666-5C3FA473-94B7-4E33-8788-1A733F9D67D2Q41732280-3FDC6E99-7CC6-4997-8B6D-FFA2BDF62FD6Q46238743-C19B6CFC-E513-4586-B844-2710D1F80219Q49165832-BC97AE22-51F1-416B-B164-1621AFC2E874Q49547317-8553EC63-E0BC-46BE-AA99-2913683AD471
P2860
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
@en
type
label
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
@en
prefLabel
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
@en
P2093
P2860
P356
P1433
P1476
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
@en
P2093
Aalok Shah
Benjamin Holmes
Bob D Brown
Darren H Wong
Garrett R Rettig
Hailin Yang
Henryk Dudek
Kathleen Wortham
P2860
P304
P356
10.1038/MT.2013.233
P577
2013-10-03T00:00:00Z